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Supplementary Table 1: Primer sequences of CRB1 gene used in this study (NM_201253.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exon Primers 5´- 3´ sequence Tm (°C) Fragment length (bp) 
1 
GTGATGCTAAGAAGCACAAAC 
60 451 
CTGACTGTTCACATTGACTGG 
2 
GAGGCAGCACAAAGGTCACA 
60 711 
GAGCTAACTACACCATCTGTG   
3 
ACAGAACATTTGACAAGTGCTC 
60 399 
GCCGAGAACGTGAGAGCTC      
4 
GATGATGCCATGGGTCTTGG 
60 318 
TCATTTGCTATAAGCGATATGTG 
5 
CAGTATAGCAGTCAACCTCC 
60 362 
CAGCTCTTCCTGCTAATACAC    
6A 
TCCATTACAGTCCTAAACCTG 
58 575 
GTAGCCACTTAGCAGCTCC       
6B 
CCGAAGCAACAGGGATGTG 
58 607 
TGCTCTGCTCTGAGGCATG       
7 
CTGTCTTTTGAGCCTTAAGATG 
60 732 
CTATACTGGTGGGTCAGTAAC 
8 
CTCTCTGCCACCACTCTGCC 
60 526 
CAGTCAGTATTAGCCTACTCG 
9A 
AGCAACTAGCACAGTATGTAAC 
60 384 
CTGACTGCAAACTTGTCAGAC 
9B 
CACATTTGGTTTCAGAACAAGG 
60 582 
GACCATCCCAAGGGACAGG 
9C 
CTCTACCAATTCAGTGGTCAC 
60 429 
GACAAGAACAGTGATGCAGAG 
10 
CTTGGCATTGACTACATACATG 
60 367 
GTTTCATTCTGTCTGAACCTC    
11 
GTGCTGTTCCAGAGAGATAAG 
60 322 
CAACTGGCTCGTCATTCATAC   
12 
TCATTCCTGAGTAGTTCCATTG 
60 368 
AGAGATACCTGAAGTACAGTC   
Supplementary Table 2. In silico analysis of CRB1 missense variants identified in the current study and evaluated as pathogenic. Six different 
algorithms were used; tolerated and neutral scores are indicated in green as benign; yellow indicates a possibly damaging variant, and red a 
probably damaging, deleterious, disease-causing mutation. NM_201253.2 and NP_957705 were taken as the reference sequences. 
DNA level Protein level SNP&GO MutPred PROVEAN SIFT PolyPhen-2 MutationTaster 
c.2308G>A p.(Gly770Ser) Neutral Disease Disease Neutral Disease Disease 
c.2843G>A* p.(Cys948Tyr) Disease Disease Disease Disease Disease Disease 
c.3121A>G p.(Met1041Val) Neutral 
Possibly 
damaging 
Disease Neutral 
Possibly 
damaging 
Disease 
*Previously reported as disease-causing, summarized in Bujakowska K., et al., 2013.  
Using MutPred an overall probability score > 0.5 was considered as probably disease-causing and a score > 0.75 was considered as disease-causing. 
 
 
  
Supplementary Figure 1. Diagrammatic representation of research approach and workflow applied in the 
search for the molecular genetic cause in Czech probands with early-onset severe retinal dystrophies. 
Time scale indicates the total amount of time spent on the analysis including associated administration to 
fulfill the national health care system requirements for payment in laboratories located outside the country 
in probands 1 and 2. 
 
 
 
 
Supplementary Figure 2. Evolutionary conservation of the CRB1 protein. T-Coffee multiple sequence 
alignment result. Amino acids at position 770, 948 and 1041 in the human CRB1 protein sequence 
(UniProtKB - P82279) are indicated by an arrow. 
 
